Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early hydrocortisone administration in sepsis
IRCT20230701058635N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of hydrocortisone in sepsis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Time to enter septic shock. Started Jan 2024; status: completed.
02
Drugs
hydrocortisone
03
Conditions
sepsis
Beyond the preview
Go deeper on IRCT20230701058635N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230701058635N1.